Back to News
Nov 25, 2025 12:00 PM

Symbotic Posts Strong Q4 And Enters Health-Care Market With First Customer

Symbotic Inc (NASDAQ:SYM) ended the fiscal year on a strong note, with upbeat fourth-quarter results, and announced its first customer in the health care vertical, according to Needham.

The Symbotic Analyst: Analyst James Ricchiuti reiterated a Buy rating and raised the price target from $57 to $70.

The Symbotic Thesis: The company's fiscal fourth quarter revenues grew 10% year-on-year to $618 million, beating consensus of $604 million, Ricchiuti said in the note.

Check out other analyst stock ratings.

Symbotic's ...